Abstract:Copper-based nanomaterials (Cu-based NMs) with favorable biocompatibility and unique properties have attracted the attention of many biomedical researchers. Cu-based NMs are one of the most widely studied materials in cancer treatment. In recent years, great progress has been made in the field of biomedicine, especially in the treatment and diagnosis of tumors. This review begins with the classification of Cu-based NMs and the recent synthetic strategies of Cu-based NMs. Then, according to the abundant and special properties of Cu-based NMs, their application in biomedicine is summarized in detail. For biomedical imaging, such as photoacoustic imaging, positron emission tomography imaging, and multimodal imaging based on Cu-based NMs are summarized, as well as strategies to improve the diagnostic effectiveness. Moreover, a series of unique structures and functions as well as the underlying property activity relationship of Cu-based NMs were shown to highlight their promising therapeutic performance. Cu-based NMs have been widely used in monotherapies, such as photothermal therapy (PTT) and chemodynamic therapy (CDT). Moreover, the sophisticated design in composition, structure, and surface fabrication of Cu-based NMs can endow these NMs with more modalities in cancer diagnosis and therapy. To further improve the efficiency of cancer treatment, combined therapy based on Cu-based NMs was introduced in detail. Finally, the challenges, critical factors, and future prospects for the clinical translation of Cu-based NMs as multifunctional theranostic agents were also considered and discussed. The aim of this review is to provide a better understanding and key consideration for the rational design of this increasingly important new paradigm of Cu-based NMs as theranostic agents. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Diagnostic Tools > In Vivo Nanodiagnostics and Imaging.

Bismuth-based two-dimensional nanomaterials for cancer diagnosis and treatment

Application of bismuth sulfide based nanomaterials in cancer diagnosis and treatment

Application of Bismuth-Based Nanomaterials in Imaging Diagnosis and Therapy for Cancer

Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy

Pnictogen Semimetal (sb, Bi)-Based Nanomaterials for Cancer Imaging and Therapy: A Materials Perspective

Functionalization of bismuth sulfide nanomaterials for their application in cancer theranostics

How Do Bismuth-Based Nanomaterials Function as Promising Theranostic Agents for the Tumor Diagnosis and Therapy?

Recent advances in functional bismuth chalcogenide nanomaterials: Cancer theranostics, antibacterial and biosensing

Two-Dimensional Nanomaterials for Cancer Nanotheranostics.

Biodegradable two-dimensional nanomaterials for cancer theranostics

2D Nanomaterials for Cancer Theranostic Applications

Copper-based Nanomaterials for Cancer Theranostics

Near‐Infrared Light‐Activatable Bismuth‐based Nanomaterials for Antibacterial and Antitumor Treatment

Recent developments in bismuth oxyhalide-based functional nanomaterials for biomedical applications

Two-dimensional nanomaterials induced nano-bio interfacial effects and biomedical applications in cancer treatment

Tailoring Bismuth-Based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

Two-dimensional layered nanomaterials for tumor diagnosis and treatment

Recent Advance Of Biocompatible Nanomaterials For The Identification, Diagnosis, And Treatment Of Cancers

Advances in the two-dimensional layer materials for cancer diagnosis and treatment: unique advantages beyond the microsphere

Biomedical Nanomaterials for Imaging-Guided Cancer Therapy

Bio-based Nanomaterials for Cancer Therapy